Osmond DGB cell development in the bone marrow. Semin Immunol1990; 2: 173-80.
4.
Opstelten D. , Osmond DGPre-B cells in mouse bone marrow: immunofluorescence stathmokinetic studies of the proliferation of cytoplasmic μ-chain-bearing cells in normal mice. J Immunol1983; 131: 2635-40.
5.
Duke RC, Cohen JJIL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res1986; 5: 289-99.
6.
Williams GT, Smith CAMolecular regulation of apoptosis: genetic controls on cell death . Cell1993; 74: 777-9.
7.
Cohen JJ, Duke RC, Fadok VA, Sellins KSApoptosis and programmed cell death in immunity. Ann Rev Immunol1992; 10: 267-93.
8.
Smith CA, Williams GT, Kingston R., Jenkinson EJ, Owen Jjt.Antibodies to CD3/T cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature1989; 337: 181-2.
9.
Benhamou LE, Cazenave P-A., Sarthou P.Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells . Eur J Immunol1990; 20: 1405-7.
10.
Kerr Jfr, Wyllie AH, Currie ARApoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer1972; 26: 239-57.
Mallet S., Barclay ANA new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol Today1991; 12: 220-3.
13.
Trauth BC, Klas C., Peters Amj et al. Monoclonal antibody-mediated tumor regression by apoptosis. Science1989; 245: 301-5.
14.
Itoh N., Yonehara S., Ishii A. et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell1991; 66: 233-43.
15.
Drappa J., Brot N., Elkon KBThe Fas protein is expressed at high levels on double positive thymocytes and activated mature T cells in normal but not MRL/lpr mice. Proc Natl Acad Sci USA1993; 90: 10340-4.
16.
Russell JH, Rush B., Weaver C., Wang R.Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA1993; 90: 4409-13.
17.
Cohen PL, Eisenberg RAlpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol1991; 9: 243-69.
18.
Allen RD, Marshall JD, Roths JB, Sidman CLDifferences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J Exp Med1990; 172: 1367-75.
19.
Sneller M., Straus S., Jaffe S. et al. A novel lymphoproliferative/ autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest1992 ; 90: 334-41.
20.
Mysler E., Bini P., Drappa J. et al. The APO-1/Fas protein in human systemic lupus erythematosus . J Clin Invest (in press).
21.
Korsemeyer SJBcl-2 initiates a new catagory of oncogenes: regulators of cell death. Blood1992; 80: 879-81.
22.
Hockenbery DM, Oltvai ZN, Yin X-M., Milliman CL, Korsmeyer SJBcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell1993; 75: 241-51.
Nakayama K-I. , Nakayama K., Negishi I. et al. Disappearance of the lymphoid system in bcl-2 homozygous mutant chimeric mice. Science1993; 262: 1584-8.
25.
Graninger WB , Aringer M., Steiner C., Smolen JSExpression of the protooncogene Bcl-2 in systemic lupus erythematosus. Arthritis Rheum1993; 36: S77 (abstract).
26.
Kumagai S., Yanagida H.Increased expression of Bcl-2 protein in peripheral B cells of patients with systemic lupus erythematosus (SLE). Arthritis Rheum1993; 36: S76 (abstract).
27.
OltvaiZn, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homologue, Bax, that accelerates programmed cell death. Cell1993; 74: 609-19.
28.
Boise LH, Garcia MG, Postema CE et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apototic cell death. Cell1993; 74: 597-608.